中文簡(jiǎn)介

人們對(duì)結(jié)核病(TB)重新燃起的興趣加快了結(jié)核病研究的步伐。結(jié)核病已重新調(diào)整方向，以便將重點(diǎn)放在基礎(chǔ)研究進(jìn)展上，特別是那些與結(jié)核病控制和最終消除有關(guān)的研究進(jìn)展。已經(jīng)成立了一個(gè)杰出的國(guó)際編輯委員會(huì)，歡迎在免疫學(xué)、免疫遺傳學(xué)、病原學(xué)、微生物學(xué)、微生物生理學(xué)、發(fā)病機(jī)理、病理學(xué)、分子流行病學(xué)、診斷、疫苗研制、藥物研制和耐藥性等領(lǐng)域作出貢獻(xiàn)。我們的目標(biāo)是結(jié)核病將發(fā)表杰出的同行評(píng)議的與結(jié)核病有關(guān)的生物醫(yī)學(xué)研究。

投稿網(wǎng)址：http://ees.elsevier.com/TUBE/

英文簡(jiǎn)介

The resurgence of interest in tuberculosis (TB) has accelerated the pace of TB research. Tuberculosis has been reoriented to allow focus on basic research advances, particularly those with relevance to TB control and eventual elimination. An outstanding international Editorial Board has been assembled and welcomes contributions in the areas of immunology,immunogenetics, pathogenetics, microbiology, microbial physiology, pathogenesis, pathology, molecular epidemiology, diagnostic, vaccine development, drug development and drug resistance. Our intent is that Tuberculosis will publish outstanding peer-reviewed biomedical research relevant to tuberculosis.